SARS-CoV-2 virus
-
A new UBC study suggests the roots of morality may be present from birth.
-
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
-
Canadian researchers lead development and testing of promising treatment for COVID-19 variants
A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.
-
UBC researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7.
-
Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents
A single dose of the Pfizer-BioNTech COVID-19 vaccine produces a much weaker antibody response in long-term care residents than it does in younger healthy adults, new research has found.
